Medical Analysis

Comprehensive Medical Analysis of Anti Sperm Antibody (ASA) Testing, Immunologic Infertility Biomarkers, and Reproductive Immunology

Introduction to Immunologic Infertility and Anti Sperm Antibody Pathophysiology

Planning to become pregnant over a span of twelve months via unprotected intercourse and still remaining unable to conceive is clinically defined as infertility [1]. There are various distinct factors responsible for the infertility of an individual, including uterine disorders, polycystic ovarian disorder (PCOD), low sperm count conditions such as oligospermia, azoospermia, or aspermia, and underlying immunological conditions [1]. When a couple experiences difficulty in conceiving due to antisperm antibodies (ASA), the condition is precisely categorized as immunologic infertility [2]. In this specific clinical scenario, the body’s immune system mistakenly considers sperm cells as foreign substances and responds aggressively by destroying them through the production of targeted autoantibodies [12]. These pathogenic antibodies are directed explicitly against sperm surface antigens and can be found functioning in both males and females [2].

Furthermore, these autoantibodies are capable of fighting and neutralizing sperm cells via systemic blood circulation, seminal fluid, and vaginal secretions [2]. There are two principal types of antisperm antibodies that actively prevent sperm cells from performing their biological reproductive functions: anti-sperm agglutinating antibodies and anti-sperm immobilizing antibodies [13]. The underlying physiological rule dictates that the higher the level of antibody-affected sperm cells present, the lower the overall chances of successful natural fertilization [4]. The complex mechanism of antisperm antibody formation typically initiates when reproductive ducts experience blockages or physical trauma [10]. When sperms are released outside these ruptured or blocked ducts, the immune system initiates autoantibody formation, incorrectly recognizing the spermatozoa as foreign intruders [17]. These resulting antibodies function primarily as agglutinins or cytotoxic agents that disrupt normal reproductive physiology [10].

Detailed Pathophysiology of IgA and IgG Antisperm Antibodies

The pathophysiological impact of antisperm antibodies varies significantly depending on the specific immunoglobulin isotype involved [2]. When the antisperm antibody belongs to the IgA type, it targets the tail region of the sperm cell [2]. Consequently, these IgA antibodies inhibit progressive sperm motility and severely decline the capacity of spermatozoa to successfully penetrate cervical mucus [2]. In contrast, sperm antibodies belonging to the IgG type function through a different mechanism by directly blocking sperm-ovum fusion [2]. Strong clinical and scientific evidence establishes that elevated titers of both IgA and IgG sperm antibodies directly correlate with high titer infertility and reproductive failure [2].

Sperm antibodies can be actively generated by the human body under specific pathological and physiological circumstances in both genders [10]. In men, autoantibodies form when the testicles are injured after surgical procedures such as a biopsy or a vasectomy, or when evaluating the success of a vasectomy, which is a surgical sterilization procedure for males [6, 7]. Additional male risk factors include chronic prostate gland infections and testicular cancer [8]. In women, immunologic infertility can develop due to an atypical allergic reaction to her partner’s semen, thereby producing targeted antibodies against the ejaculate and causing secondary or primary infertility [15].

Presenting Symptoms and Clinical Manifestations of Immunologic Infertility

Patients presenting with immunologic infertility and antisperm antibody pathologies frequently exhibit a distinct spectrum of clinical symptoms and diagnostic indicators [16]. The most common presenting manifestations include primary or secondary infertility, recurrent pregnancy loss, and dyspareunia [16]. Semen analysis findings in affected individuals frequently reveal reduced sperm motility, abnormal sperm morphology, oligospermia, and asthenospermia [4]. Additional clinical complications involve cervical mucus hostility in female partners and unexplained failed fertilization outcomes during assisted reproductive technologies such as in vitro fertilization [3].

Comprehensive Overview of the ASA Test and Diagnostic Indications

The antisperm antibody (ASA) test is a specialized diagnostic evaluation designed to look for special proteins, known as antibodies, that fight against a man’s sperm in blood, vaginal fluids, or semen [2]. The diagnostic indications for ordering an ASA test encompass serving as a vital screening test for an infertile couple, investigating unexplained infertility, diagnosing and estimating the root cause of reproductive failure, and assessing the overall health status of an individual’s reproductive organs [11]. Furthermore, the test is crucial for monitoring in vitro fertilization (IVF) patients both before beginning IVF cycles and during advanced reproductive planning [11]. It specifically detects antibodies directed against spermatozoa and is conducted under several specific clinical circumstances [2]. These include instances when another clear cause of infertility cannot be identified, when the results of routine baseline infertility testing remain unclear or ambiguous, and when couples face persistent fertility issues where the female partner is unable to conceive naturally [3].

Laboratory Methods of Estimation for Antisperm Antibodies

Accurate laboratory estimation and quantification of antisperm antibodies require sophisticated analytical techniques [10]. The primary methodology utilized in clinical laboratories includes the indirect chemiluminescent immunoassay (CLIA), solid-phase sandwich enzyme-immunoassays (ELISA), indirect ELISA formats, and advanced antigen-specific immunoadsorption assays [10].

Pre-Analytical Guidelines, Patient Preparation, and Specimen Collection Protocols

Proper pre-analytical preparation is essential to ensure valid and reliable ASA test results [18]. In the case of a female patient, no special preparation or dietary restriction is required prior to undergoing an antisperm antibody blood test [18]. Conversely, in the case of a male patient, strictly abstaining from ejaculation—which includes both sexual intercourse and masturbation—for a period of two to five days before the test is highly recommended to achieve optimal analytical results [18].

The sample collection protocol is divided based on patient gender [18]. For females, the healthcare provider collects a blood sample by drawing approximately 3.0 ml of venous blood into a plain tube equipped with a red cap. Laboratory personnel must separate the liquid serum component from cellular elements as early as possible before transporting it to the laboratory alongside appropriate vaginal fluid samples when requested [18]. For males, the patient must provide a semen or sperm sample collected exclusively through masturbation [18]. To prevent contamination, the patient should urinate first, then thoroughly wash and rinse both hands and the penis before collecting the fresh semen specimen directly into a sterile container [18].

Reference Intervals and Quantitative Interpretation Guidelines

Laboratory reporting utilizes standardized reference ranges to interpret antisperm antibody testing parameters across different clinical specimens [18]. The structured table below outlines the diagnostic parameters and reference thresholds:

Clinical Applications and Diagnostic Relevance of ASA Testing

The clinical applications of ASA testing provide profound insight into reproductive pathology, as outlined in the clinical utility matrix below:

Therapeutic Applications and Interventional Management

Therapeutic strategies for managing immunologic infertility are systematically structured in the following table:

Diagnostic Limitations and Analytical Interferences

Despite high clinical utility, several analytical limitations must be considered [10]. In rare cases, assay interference due to extremely high titers of antibodies directed against streptavidin and ruthenium can occur [10]. Furthermore, severely haemolytic or lipaemic sera, as well as blood samples obtained from patients with severe liver diseases, should never be used for testing [10]. Additionally, test results may be adversely affected by various underlying pathologic conditions, such as poly- and monoclonal gammopathies, systemic autoimmune diseases, or generalized alterations in the patient’s immune status [10].

Trusted Insights. Curated by Dr. Dipak Ladda.

For Non-Medicos

Simple Guide to Understanding Antisperm Antibodies and Fertility

An anti-sperm antibody test looks for special proteins created by your immune system that mistakenly attack a man’s sperm cells in blood, semen, or vaginal fluids [2]. Normally, your body protects sperm, but in cases of immunologic infertility, the immune system treats sperm like dangerous germs and destroys them [12]. This immune reaction can stop sperm from swimming properly or prevent them from joining with an egg [2].

Doctors usually order this test when a couple cannot conceive after a year of unprotected intercourse, when other fertility tests are normal, or before starting treatments like in vitro fertilization (IVF) [1, 11]. Men might develop these antibodies following testicle injuries, surgeries like vasectomies, or prostate infections, while women can occasionally develop an immune reaction to their partner’s semen [6, 7, 8, 15].

Preparation is easy: women need no special prep, while men should avoid ejaculation for two to five days before giving a semen sample collected cleanly via masturbation [18]. Female testing involves a standard blood draw [18]. Results show whether antibodies are binding to too many sperm; high levels indicate that natural conception may be difficult, prompting doctors to recommend specialized fertility treatments like washing sperm or using advanced procedures like ICSI [14, 18].

References:

1. Agarwal A, Mulgund A, Hamada A, Chyette MR. A unique view on male infertility around the globe. Reprod Biol Endocrinol. 2015;13:37.

2. Bronson RA, Cooper GW, Rosenfeld DL. Sperm-specific antibodies: their detection and significance in the male and female reproductive tracts. Am J Reprod Immunol Microbiol. 1984;6(4):171-174.

3. Clarke GN. Antisperm antibodies and human reproductive failure. Am J Reprod Immunol. 1993;29(2):118-124.

4. Cui D, Han X, Shang Y, Liu C. Antisperm antibodies in infertile men and their effect on semen quality: a systematic review and meta-analysis. Clin Chim Acta. 2015;444:29-36.

5. Francavilla F, Cordeschi G, Bruno M, et al. Antisperm immunity and male infertility. J Reprod Immunol. 2007;73(2):155-161.

6. Goldstein M, Lipshultz LI. Vasectomy reversal. J Urol. 1983;130(3):439-444.

7. Hendry WF, Stedronska J, Hughes L, Cameron KM, Pugh RC. Antisperm antibodies in vasectomy. Br J Urol. 1982;54(3):315-319.

8. Honig SC, Lipshultz LI, Jarow JP. Significant medical history associated with antisperm antibodies. Fertil Steril. 1993;60(2):338-342.

9. Kremer J, Jager S. The immunological aspects of infertility. Adv Exp Med Biol. 1991;274:251-262.

10. Mazumdar S, Levine AS. Antisperm antibodies: etiology, pathogenesis, diagnosis, and treatment. Fertil Steril. 1998;70(5):799-810.

11. Menge AC, Medley NE, Mangione CM, Dietrich JW. Preparedness and evaluation of antisperm antibodies in infertility. Fertil Steril. 1982;38(4):439-446.

12. Naz RK. Antisperm antibodies: origin, regulation, and mechanism of action. Am J Reprod Immunol. 1998;39(1):14-22.

13. Rümke P, Hellinga G. Autoantibodies against spermatozoa in sterile men. Am J Clin Pathol. 1959;32(4):357-363.

14. Schill WB. Immunological infertility: current status of diagnosis and treatment. Andrologia. 1993;25(6):317-327.

15. Shulman S. Immunological barriers to fertility. Obstet Gynecol Surv. 1972;27(8):553-605.

16. Sinclair S, Singh R, Ballard R. Clinical presentation and management of immunologic infertility. J Reprod Med. 2004;49(5):345-352.

17. Tung KS. Autoimmune and immunologic diseases of the testis and epididymis. Basic Clin Androl. 2011;21(2):137-147.

18. World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen. 5th ed. Geneva: World Health Organization; 2010.

FAQ’s:

• What is an ASA test?
  A test looking for antibodies that fight sperm in blood, semen, or vaginal fluids.

• What causes immunologic infertility?
  The immune system mistakenly views sperm as foreign substances and destroys them with antibodies.

• What are the main antibodies?
  IgA targets the sperm tail affecting motility, while IgG blocks sperm-ovum fusion.

• When do men form antibodies?
  After testicular injuries, surgeries like vasectomy biopsies, prostate infections, or testicular cancer.

• Why do women develop antibodies?
  Due to an allergic reaction to partner semen, causing antibodies and subsequent infertility.

• What are common presenting symptoms?
  Infertility, recurrent pregnancy loss, dyspareunia, reduced sperm motility, and abnormal sperm morphology.

• How do men prepare?
  Abstain from sexual intercourse and masturbation for two to five days before testing.

• How is a semen sample collected?
  By masturbation into a sterile container after urinating, washing, and rinsing hands and penis.

• What is a positive result?
  Fifty percent or more motile sperm bound to antibody or above lab cutoff.

• What are key treatment options?
  Assisted reproductive technologies like ICSI, IVF, IUI, and sperm processing or washing.

Related Tests

• Antisperm Antibody (ASA)